Answers are grounded in this paper and cite their sources.
SUMMARY Currently in the developed world, the risks of infection by the transfusion of blood components is very low. Improved methods of selection of all voluntary donors as well as highly sensitive screening techniques to detect the most important agents known to be transmissible by blood transfusion have greatly improved the safety of the blood supply. Nevertheless, there is still the risk of transmitting (mainly HBV, HCV, HIV, CMV, etc.), bacteria (e.g. staphylococci, Pseudomonas, Yersinia) and parasites (e.g. malaria and T. Cruzi).Transmissions occur because donors gave blood during the ‘window period“, because of error, or because no screening test is available for that agent. No cases of new variant Creutzfeldt‐Jakob disease (or CJD) nor of any transmissible spongiform encephalopathy have been shown to be transmitted by blood transfusion. However, because bovine spongiform encephalopathy (BSE) (”mad cow disease“) acquired epidemic proportions only in the U.K. (with the exception of one out of 45 cases), the British Department of Health has decided to introduce several prophylactic measures that might reduce the hypothetical risk of transmission by blood transfusion, such as universal leukodepletion and disposal of all volunteer U.K. plasma for fractionation with its replacement by imported non‐volunteer plasma from the U.S.A
No takes yet. Share an insight, caveat, or question.
Contreras et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: